Form 4: Standex International Director Sells Shares
Insider Transaction Report
Thomas E. Chorman, a Director at Standex International Corp., has reported the sale of 50 shares of common stock.
Summary
- Thomas E. Chorman, a Director of Standex International Corp., sold 50 shares of common stock on May 1, 2026.
- The sale was executed at a price of $268.43 per share.
- Following this transaction, Mr. Chorman beneficially owns 12,516 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the sale was conducted under a pre-established 10b5-1 trading plan, mitigating concerns about insider knowledge influencing the transaction.
Negatives
- Director sale of company stock can sometimes be perceived negatively by the market, though this sale was part of a pre-arranged plan.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors. However, sales made under a Rule 10b5-1 plan are generally viewed as pre-arranged and not necessarily indicative of a negative outlook on the company's future performance, as they are executed based on a predetermined schedule and price.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| 10b5-1 Trading Plan | Sale of stock was made pursuant to an existing 10b5-1 trading plan dated November 6, 2025. | 2025-11-06 | Demonstrates adherence to established corporate governance practices for insider stock transactions, providing a defense against allegations of insider trading. |
Stakeholder Impact
- Shareholders: May observe the transaction, but the 10b5-1 plan context suggests it's not a signal of negative company performance.
Key Dates
| Date | Description |
|---|---|
| 2025-11-06 | Date of the 10b5-1 trading plan established for the stock sale. |
| 2026-05-01 | Transaction date for the sale of common stock. |
| 2026-05-04 | Date the Form 4 was signed by the reporting person. |
Keywords
Standex International, SXI, Form 4, Insider Trading, Stock Sale, Director Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.